[Analgesic effects and hemodynamic and respiratory repercussions of the fentanyl-droperidol combination in the acute stage of myocardial infarction].
D000328:Adult; D000368:Aged; D001544:Benperidol / Q000627:therapeutic use*; D001784:Blood Gas Analysis; D001794:Blood Pressure / Q000187:drug effects; D002090:Butyrophenones / Q000627:therapeutic use*; D002302:Cardiac Output / Q000187:drug effects; D002986:Clinical Trials as Topic; D004329:Droperidol / Q000627:therapeutic use; D005260:Female; D005283:Fentanyl / Q000009:adverse effects / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics; D006801:Humans; D000860:Hypoxia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D012129:Respiratory Function Tests; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D002090:Butyrophenones; D014149:Tranquilizing Agents; D001544:Benperidol; D004329:Droperidol; D005283:Fentanyl
Effets analgésiques et répercussions hémodynamiques et respiratoires de l'association fentanyl-dropéridol à la phase aiguë de l'infarctus du myocarde.